Welcome to TUCL Repository
- Access to a vast collection of academic theses and dissertations
- Wide range of scholarly journals and articles
- Search and browse functionalities for easy discovery of resources
- Accessibility to digital resources anytime, anywhere
- Facilitates research and learning endeavors of TUCL community
- Promoting open access to knowledge and research findings
- User-friendly interface, ensuring ease of navigation and accessibility for users of all levels of expertise
- unique persistent identifier (such as DOI or Handle) to facilitate citation, tracking, and long-term preservation, ensuring the integrity and longevity of scholarly contributions

Communities in DSpace
Select a community to browse its collections.
Recent Submissions
Mutation analysis of dystrophin gene using multiplex ligation dependent probe amplification (MLPA)
(2013) Shrestha, Kushal; Rohit Kumar
Duchenne muscular dystrophy (DMD), an allelic X-linked progressive muscle-wasting
disease, and its allelic form Becker muscular dystrophy (BMD) are one of the most
common single-gene disorders caused by mutations in the DMD gene (also dystrophin
gene), the longest known human gene ranging 2.4 Mb, encoding a 427 kDa cytoskeletal
protein called dystrophin. Due to the lack of reliable genetic diagnostic tool in Nepal the
diagnosis of these genetic diseases are narrowed to phenotypic and clinical diagnoses.
Besides, the lack of even the base line data of these genetic diseases has barred the
progression of the further research of these genetic diseases in Nepal.This research has
been carried out with the aim to introduce Multiplex ligation dependent probe
amplification (MLPA) as one of the convenient molecular diagnostic tool in diagnosis of
the genetic diseases as DMD/BMD.
In this research, DNA was extracted from the blood samples of DMD/BMD patients and
from the normal male and female to be taken as the reference samples. DNA samples so
extracted were then amplified in the thermocycler by using the MLPA assay. The PCR
products of the test samples and the reference samples so obtained were run on the
capillary electrophoresis (CE) and the data were analysed. Using an algorithm of MLPA,
26 total samples were assayed. The capillary electrophoresis run (ABI-310 genetic
analyzer) demonstrated that it could pick up the deletions in 14 of the 21 test samples
considered. Consequently, MLPA was efficient in accurately confirming mutations in
about 67% of all cases. Most prevalent exonic deletion regions were found to be
confined in the exon 7-14, the proximal zone and 45-53, the first half of C-terminal
domain. The reading frame (in-frame or out-frame) were determined by using the “DMD
exonic deletions/duplications reading frame checker 1.9” as recommended by MRCHolland,
which need to be confirmed by sequencing.No novel mutations were identified in
this study. Overall, this approach confirmed mutations in 67% of the patients in our
study which is compatible with the recent studies in Chinese and Indian population.
Among the 21 test samples used MLPA could not diagnose the mutation in some of the
samples which were clinically diagnosed as DMD/BMD. This result aware us that in order
to know the exact point of mutation and to know exactly which of the exon is deleted or
duplicated further sequencing should be done. But still the efficiency of this MLPA assay
makes it a rapid, robust, efficient and reliable genetic tool in the diagnosis of genetic
disorders. The systematic approach/algorithm used in this study offers the best possible
less invasive and effective mutation analysis in the context of Nepal.
Key words: Dystrophin gene, Duchenne muscular dystrophy (DMD) and Becker muscular
dystrophy (BMD), Multiplex Ligation Dependent Probe Amplification (MLPA), capillary
electrophoresis (CE) 1
In Silico Drug Repurposing against Salmonella Typhimurium LT 2 Dam Protein
(2023) Maharjan, Suja; Pramod Aryal
The increasing prevalence of Multidrug-Resistant (MDR) pathogens has resulted in
the failure of current antibiotics to effectively treat these infections. ComputerAided Drug
Discovery CADD) has become a crucial tool in the drug discovery process
recently.
It has been demonstrated to be a successful method for screening lead
compounds against target proteins within a short amount of time and with optimal
resources. In the present study, a computational approach, CADD tools were
employed to identify novel drug candidates against Salmonella enterica serovar
Typhimurium LT2, targeting its essential gene, Dam. Virtual screening of various
ligand libraries was conducted. From the initial library consisting of 21,000
compounds from natural products, 10,342 compounds from indole derivatives, 1,685
compounds from Kinase Inbibitors and 3,118 compounds from Nucleoside mimetics
after ADME/Tox and druglikeness filters were narrowed down the number of
compounds to 205 Natural Products, 462 Indole Derivatives, 6449 Kinase Inhibitors,
and 654 Nucleoside Mimetics. The final screening from molecular docking and
binding energy resulted in the identification of four lead compounds, Antineo plaston
A10 and Cardamonin from natural products, 5-cyclopentaneamido-1-ethyl-N-(2 meth oxyethyl)-1H-indole-2-carboxamide
from Indole Derivatives, 2[[anilino (oxo)methyl]amino]-4,5-dimeth oxybenzoic
acid from Kinase Inhibitors and
3-[[[4-[2-(3,5-Dimethylpyrazol-1-yl)ethoxy]phenyl]methylamino]methyl]-1-(6methylpyrimidin-4-yl)pyrrolidin-3-ol
from Nucleoside Mimetics were identified as
potential leads. These compounds showed higher binding affinity with the target
protein and lower binding efficiency for human hMAT1A protein compared to the
reference compound S-Adenosyl methionine (SAM) and S-adenosyl homocysteine
(SAH). The stability and strength of protein-ligand binding were observed through
protein-ligand interactions, Density Functional Theory (DFT), analysis of frontier
molecular orbitals and vibrational spectra. The results suggest that these compounds
may be potential candidates for further exploration against other MDR pathogens
prioritized by the World Health Organization (WHO).
Keywords: CADD, Multidrug-Resistant, Dam, essential gene, lead compounds
Physicochemical and Microbial Profiling of Kefir from Cow and Buffalo Milk; Implications for Probiotic Use
(2024) Soni, Sushmita; Jarina Joshi
Kefir, a traditional fermented dairy product, is valued for its unique taste, thickness, and
health benefits attributed to its rich microbial diversity. This study aimed to investigate the
processing, physiochemical properties, and probiotic profile of kefir, particularly focusing
on its therapeutic potential. The introduction highlights kefir's historical and contemporary
significance, including its increasing popularity as a functional food. The problem statement
addresses the rising prevalence of digestive issues and the need for effective dietary
interventions like kefir. Kefir, with its high probiotic content, offers potential health
benefits, including improved gastrointestinal health and immune function. The specific
objectives include producing kefir using traditional fermentation methods, identifying the
microbial strains present, and characterizing their probiotic properties. The study utilized
traditional kefir fermentation methods with kefir grains. Physiochemical analyses of kefir
and metagenomic profiling of lactic acid bacteria and yeasts from kefir were conducted.
This study investigated the isolation, identification, and probiotic characterization of lactic
acid bacteria (LAB) and yeast from kefir, identifying strains such as Lactobacillus helveticus,
Lactobacillus rhamnosus, Lactobacillus fermentum, Kazachstania martinaie, and Pichia
chibdodasensis. The isolates exhibited distinct morphological, biochemical, and genetic
characteristics, confirmed through PCR amplification of the 16S rRNA and 18S rRNA genes.
Among the LAB, Lactobacillus helveticus showed the highest acid tolerance at lower pH
levels (2.5 and 3), while L. rhamnosus performed best at mildly acidic to neutral conditions
(pH 5.6). L. helveticus also demonstrated superior bile salt tolerance, autoaggregation
(65%), coaggregation (30%), and hydrophobicity (40%). All strains tolerated lower salt
concentrations (2% and 5%) well, with L. rhamnosus showing the highest overall salt
tolerance. L. fermentum exhibited the highest phenol tolerance, while L. rhamnosus and L.
fermentum formed biofilms, unlike L. helveticus. Lastly, L. helveticus displayed the highest
bile salt hydrolase activity (+++), followed by moderate activity in L. rhamnosus and L.
fermentum (++). L. helveticus showed superior antibiotic susceptibility, and notable
antimicrobial activity, particularly against E. coli and Staphylococcus aureus. In contrast, L.
rhamnosus exhibited effectiveness against Pseudomonas aeruginosa. These findings
indicate L. helveticus as a promising probiotic candidate, suggesting its application in
enhancing gastrointestinal health. Buffalo milk kefir differs notably from cow dairy milk
kefir in pH, acidity, Degree Brix, and HPLC-measured concentrations of organic acids and
sugars. Buffalo milk kefir shows higher pH (4.7 ± 0.082), lower acidity (1.37 ± 0.024%), and
higher lactose content (32.92 ± 0.088 mg/ml) compared to cow dairy milk kefir, which has
lower pH (4.5 ± 0.082), higher acidity (1.96 ± 0.033%), and lower lactose content (18.02 ±
0.061 mg/ml). Significant yeast growth, essential for ethanol production, was observed in
buffalo milk kefir, contributing to its distinctive flavor and aroma. The findings confirmed
kefir's rich probiotic content and beneficial physiochemical properties. These findings
support the broader use of kefir in dietary interventions aimed at improving overall health.
Further research should focus on standardizing kefir production methods and conducting
clinical trials to substantiate its health benefits. Additionally, promoting kefir consumption
could help address common digestive health issues, especially in regions with limited
access to healthcare.
Keywords : Kefir, fermented dairy product, probiotics, therapeutic potential, digestive
health, lactic acid bacteria (LAB), yeasts, antimicrobial activity, functional food, dietary
interventions, HPLC, lactic acid.
